Evidence map›Paper›PMID 28165007›Full record

ArticleNature communications2017

FAK signalling controls insulin sensitivity through regulation of adipocyte survival.

Cynthia T Luk, Sally Yu Shi, Erica P Cai, Tharini Sivasubramaniyam, Mansa Krishnamurthy, Jara J Brunt, Stephanie A Schroer, Daniel A Winer, Minna Woo

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Integrin signaling pathways in mesenchymal stem cells.Stem cell research & therapy · 2025
    Review
  7. Focal Adhesion Kinase Orchestrates GLUT4 Translocation and Glucose Uptake via Cytoskeletal Turnover in Primary Adipocytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Cynthia T LukToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Sally Yu ShiToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Erica P CaiToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Tharini SivasubramaniyamToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Mansa KrishnamurthyToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Jara J BruntToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Stephanie A SchroerToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Daniel A WinerToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Minna WooToronto General Hospital Research Institute, University Health Network, MaRS Ctre, TMDT, 101 College Street, 10th Floor, Room 10-363, Toronto, Ontario, Canada M5G 1L7.
Toronto General Hospital · CAUniversity of Toronto · CAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal adhesion kinase (FAK) plays a central role in integrin signalling, which regulates growth and survival of tumours. Here we show that FAK protein levels are increased in adipose tissue of insulin-resistant obese mice and humans. Disruption of adipocyte FAK in mice or in 3T3 L1 cells decreases adipocyte survival. Adipocyte-specific FAK knockout mice display impaired adipose tissue expansion and insulin resistance on prolonged metabolic stress from a high-fat diet or when crossed on an obese db/db or ob/ob genetic background. Treatment of these mice with a PPARγ agonist does not restore adiposity or improve insulin sensitivity. In contrast, inhibition of apoptosis, either genetically or pharmacologically, attenuates adipocyte death, restores normal adiposity and improves insulin sensitivity. Together, these results demonstrate that FAK is required for adipocyte survival and maintenance of insulin sensitivity, particularly in the context of adipose tissue expansion as a result of caloric excess.

Indexed as

3T3-L1 CellsAdipocytesAdipose TissueAdiposityAdultAnimalsApoptosisCell SurvivalDiabetes Mellitus, Type 2Diet, High-FatDisease Models, AnimalFemaleFocal Adhesion Kinase 1HumansHypoglycemic AgentsInsulinFocal Adhesion Kinase 1Hypoglycemic AgentsInsulinPPAR gammaPTK2 protein, humanPtk2 protein, mouseRosiglitazoneThiazolidinediones

Identifiers

PMID28165007
PMCPMC5303880
OpenAlexW2586566142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.